Tyco Seeking Respiratory, Anesthesiology Lines In Wake Of USSC Purchase
This article was originally published in The Gray Sheet
Executive Summary
After moving to shore up its operating room product lines with the pending acquisition of U.S. Surgical, Tyco International is looking to expand its respiratory and anesthesiology offerings.
You may also be interested in...
Mallinckrodt Nellcor Puritan Bennett Line Breathes New Air Into Tyco
Tyco International's decision to account for its $4.2 bil. stock acquisition of Mallinckrodt as a purchase rather than a pooling-of-interests transaction, gives the company the flexibility to divest Mallinckrodt's imaging drugs and bulk pharmaceuticals businesses and concentrate on the fast-growing respiratory products division.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.